Rescue of Pap-Mas in Systemic JIA Using Janus Kinase Inhibitors, Case Report and Systematic Review

Introduction: Biological disease-modifying anti-rheumatic drugs (bDMARDs) targeting interleukin (IL)-6 and IL-1β represent a steroid-sparing first-line therapy used in systemic-onset juvenile idiopathic arthritis (sJIA). Recently, the occurrence of pulmonary alveolar proteinosis (PAP) in sJIA patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Zekre, Franck, Duncan, Anita, Laurent, Audrey, Tusseau, Maud, Pescarmona, Rémi, Collardeau-Frachon, Sophie, Ohlmann, Camille, Viel, Sébastien, Reix, Philippe, Benezech, Sarah, Belot, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095381/
https://www.ncbi.nlm.nih.gov/pubmed/37048785
http://dx.doi.org/10.3390/jcm12072702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095381/
https://www.ncbi.nlm.nih.gov/pubmed/37048785
http://dx.doi.org/10.3390/jcm12072702

Ejemplares similares